Wednesday, November 4, 2009

BioCryst partner seeks peramivir approval in Japan (AP via Yahoo! News)

BioCryst Pharmaceuticals Inc. said Wednesday its partner Shionogi & Co. filed for approval to market BioCryst's IV flu drug peramivir in Japan.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)